F552 in Rhode Island. Pick another state for the same tag.
Against expectation — 2025
Rhode Island cites F552 less often than its own record predicts
Versus expected share0.64×
0.64 times the national share — cited less often here than elsewhere.
Share of Rhode Island citations0.35%
Of every deficiency written in Rhode Island in 2025, this is the portion that was F552.
Rhode Island0.35%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Rhode Island surveyors wrote
F552 findings written in Rhode Island, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
E · No harm, potential for more than minimal, patternJuly 13, 2026
Based on clinical record review and staff interview, the facility failed to inform the resident or the resident's appointed representative, in advance, of the care to be furnished by the physician or other provider, of the risks and benefits of proposed care or treatment alternatives relative to the ordering of, and administration of, psychotropic medications (a prescription drug designed to alter brain chemistry thus affecting a person's mind, emotions, and behavior) for 5 of 5 residents reviewed for unnecessary medications, Resident ID #s 1, 3, 4, 5 and 30, and for 1 of 1 resident reviewed for mood and behavior, Resident ID #28.Findings are as follows:A. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction